EHO

EHO

TBA
20,678 Views
Innovative proprietary technology to produce pressure sensitive and stretching sensitive textile sensor systems. Combining textile sensor data with data interpretation algorithms, EHO solutions provide meaningful motion analysis for monitoring horse and rider performance.
7.3
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

8
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
Dates: TBA
Whitelist/KYC: KYC
Country: Latvia
Token info
Ticker: EHO
Platform: Ethereum
Token Type: ERC20
Financial
ICO Price: 1 EHO = 0.01 USD
Accepting: ETH, BTC
Soft cap: 950,000 USD
Hard cap: 1,750,000 USD
2016
The team meets in Green Technology Incubator, Latvia.<br /> <br /> <br /> Various technology applications are assessed.<br /> <br /> <br /> Team decides to focus primarily on equestrian industry as the market potential is huge and customers have unsolved problem.
2017
Team is bootstrapping the business concept and creates laboratory level prototypes.<br /> <br /> <br /> Numerous client interviews and prototype tests are done to understand the job that product has to do for customers.<br /> <br /> <br /> Team invests 20k EUR and attracts additional 15k EUR form Riga Technical University for product development.<br /> <br /> <br /> EHO achieves significant progress with prototyping and attracts coverage by Latvian media, thus creating interest in horse riding community.<br /> <br /> <br /> Team participates in highly competitive business idea contest held by Riga City Municipality and ranks as #1 among all inventions, thus also raising 12k EUR as a grant.
Q1 2018
Creation of MVP.<br /> <br /> ICO launch.
Q2 2018
Finishing MVP, testing with early adopters.<br /> <br /> Product development.<br /> <br /> Production set-up & tests with customers.<br /> <br /> Presales for product start ICO finish.<br /> <br /> Roadshow in Royal Windsor Horse Show, UK.
Q3 2018
First batch of products shipped.<br /> <br /> Development of mobile application & server connections for data services.<br /> <br /> Roadshow in European Horse Fair, Germany.
Q4 2018
Development of deep machine learning algorithms (i.e., AI functionality).<br /> <br /> Roadshow in International Equine Trade Exhibition, UAE.<br /> <br /> Launch of data services to ensure recurring revenue from customers(includes mobile apps, usage of data servers and deep machine learning to provide customers with valuable data about horse riding patterns and possible improvements).
2019
Launch of data services to ensure recurring revenue from customers, that includes mobile apps, usage of data servers and deep machine learning to provide customers with valuable data about horse riding patterns and possible improvements.<br /> <br /> <br /> Further development of data services, introductions of self-couching service for smart saddle pad users.<br /> <br /> <br /> Development of other technology applications & smart fabric products.
Screenshots taken on 7 Apr 2018
Oskars Priede
Co-founder & CEO
Participates in a number of projects
Davids Stebelis
CMO
Participates in a number of projects
Aleksejs Katasevs
Research & Development
No participating data
Aleksandrs Okss
Research & Development
No participating data
Antons Sapriko
CEO & Founder of Scandiweb COO and Co-founder of Publica.com
Participates in a number of projects
Gleb Vrevsky
COO of Scandiweb
Participates in a number of projects
Aigars Pavlovics
CMO of Scandiweb
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Sponsy
Sponsy is disrupting the sponsorship industry. It is a one-stop online solution for sponsors and sponsees to conduct sponsorship deals. By tokenizing sponsorship assets and decentralizing decision-making, we do not only reduce costs, but also provide sponsees with a wider choice of sponsorship opportunities and make sponsorships available to every business.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.
Upcoming
Quarteria
Our mission is to create the first international decentralized residential and commercial real estate listings database controlled by both Buyers and Sellers. Real Estate Brokers and self-represented Sellers will be able to upload their listings and eventually, transfer title of properties, all paid for via the PROQ token.
Upcoming
Potentiam
The founders of Potentiam have worked in music management for a number of years and realise and understand the difficulties involved in promoting new emerging music artists. In 2016 they founded a music publication Britznbeatz to help discover and promote musicians which continues to gain respect and recognition in the industry.
Active
Tempo
Tempo is a French licensed, Paris-based, European-wide anchor for Stellar blockchain payments. The company offers online, offline and digital backed remittances to nearly 100 destination countries with over 300 physical agent locations. Tempo is creating the easiest, fastest and most secure bridge between cash and crypto.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.